MedPath

Effect of Inderal with and without Rosuvastatin on migraine attacks

Phase 2
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20120215009014N267
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Age of 18 to 65 years;
Migraine;
Serum level of LDL between 150 to 160 mg/dl

Exclusion Criteria

Pregnancy or breastfeeding;
Liver or renal failure;
Memory impairment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of migraine attacks. Timepoint: At the end of the first, second, third, and fourth weeks. Method of measurement: By history taking.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath